Benefit-Risk Balance for Medicinal Products: Report Summary from the Council for International Organizations of Medical Sciences (CIOMS) Working Group XII

Clinical Therapeutics · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles